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Abstract
Objective—To evaluate the association between diet in relation to its inflammatory property and 
bladder cancer (BC) risk .
Methods—In this study we explored the association between the dietary inflammatory index 
(DII) and BC risk in an Italian case-control study conducted between 2003 and 2014. Cases were 
690 patients with incident, histologically confirmed cases of BC from 4 areas in Italy. Controls 
were 665 cancer free subjects admitted to the same network of hospitals as cases for a wide 
spectrum of acute, non-neoplastic conditions. The DII was computed based on dietary intake 
assessed using a reproducible and valid 80-item food frequency questionnaire. Odds ratios (OR) 
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were estimated through logistic regression models adjusting for age, sex, total energy intake, and 
other recognised confounding factors.
Results—Quartile 4 (DII=0.41, 4.58; cases=207) had higher number of participants compared to 
quartile1 (DII=−5.94, −2.41; cases=124) Subjects in the highest quartile of DII scores (i.e., with a 
more pro-inflammatory diet) had a higher risk of BC compared to subjects in the lowest quartile 
(i.e., with an anti-inflammatory diet) (ORQuartile4vs1= 1.97, 95% confidence interval, 1.28, 3.03; p-
trend=0.003). Stratified analyses produced stronger associations between DII and BC risk among 
females (ORQuartile4vs1= 5.73; 95%CI=1.46, 22.44), older ≥65 years (ORQuartile4vs1= 2.45; 
95%CI=1.38, 4.34), subjects with higher education ≥7 years (ORQuartile4vs1= 2.22; 95%CI=1.27, 
3.88) and never smokers (ORQuartile4vs1= 4.04;95%CI=1.51, 10.80).
Conclusion—A pro-inflammatory diet as indicated by higher DII scores is associated with 
increased BC risk.
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Introduction
Bladder cancer (BC) is the 9th most common cancer worldwide, 1 the 6th most common 
cancer worldwide in men and the 19th most common cancer in women, with approximately 
38 000 deaths per year in the European Union.1, 2 Major recognized risk factors for BC are 
tobacco smoking, and past occupational exposure to aromatic amines.2
Considerable evidence has been gathered over the past few years linking increased cancer 
risk with chronic inflammation, and several clinical and experimental studies have linked 
tumour progression with the upregulation of pro-inflammatory molecules, especially during 
late stages of the disease.3 In addition to chronic inflammation, intrinsic properties of 
premalignant cells and other determinants promote tumour initiation and promotion.4 
Evidence from developed countries shows substantial evidence on the role of chronic 
inflammation in urological cancers, including BC.5
Dietary components such as fruits, vegetables and coffee have been studied in relation to 
incident BC in various studies.6, 7 Dietary patterns characterizing the Western-type diet; i.e., 
including high consumption of red meat, high-fat dairy products, and refined grains, have 
been associated with higher levels of c-reactive protein (CRP), interleukin-6 (IL-6), and 
fibrinogen.8 On the other hand, the Mediterranean diet –characterized by a high 
consumption of whole-grains, fruit and green vegetables, fish, and olive oil, a low 
consumption of red meat and butter, and a moderate alcohol and dairy products consumption 
– has been associated with lower levels of inflammation.9 Despite the circumstantial 
evidence, the possible relation between inflammation deriving from dietary exposure and 
BC risk has been investigated widely.
The literature-derived dietary inflammatory index (DII) was developed to assess the 
inflammatory potential of an individual’s diet.10 Higher DII scores indicate increasing 
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inflammatory potential of diet. The DII has been validated with various inflammatory 
markers, including CRP,11 IL-6,12 and tumor necrosis factor.12
The DII has been associated with a variety of cancers, including urological cancers, such as 
prostate, 13, 14 colorectal,15 esophageal,16 and breast.17. DII and urothelial cancer 
association has been explored in one Australian prospective study before.18 This large case-
control study conducted in Italy,19, 20 provides us the opportunity to examine the association 
between DII scores and BC risk. Our working hypothesis is that increasing inflammatory 
potential of diet is associated with increased risk of BC.
Methods
Design and Participants
Between 2003 and 2014, we conducted a case-control study on BC in 4 Italian centres: 
Aviano and Milan (in Northern Italy), and Naples and Catania (in Southern Italy).19, 20 
Controls were patients admitted to the same network of hospitals as cases for a wide 
spectrum of acute, non-neoplastic conditions unrelated to tobacco smoking and alcohol 
consumption or long-term diet modification (e.g., bronchitis, myocardial infarction). 
Overall, 28.9% of controls were admitted for traumas, 22.1% for non-traumatic orthopaedic 
disorders, 39.3% for acute surgical conditions, and 9.8% for other miscellaneous illnesses. 
The study protocol was approved by the Institutional Ethics Committees of each of the 
hospitals, and all subjects signed an informed consent..
Centrally trained and supervised interviewers collected information on socio-demographic 
characteristics, anthropometric measures, lifestyle habits, including tobacco smoking, and 
history of selected diseases during their hospital stay using a structured questionnaire. Each 
subject’s usual diet during the 2 years prior to cancer diagnosis (for cases) or hospital 
admission (for controls) was assessed using an interviewer-administered food frequency 
questionnaire (FFQ), consisting of 80 items on foods items and 15 (alcoholic and non-
alcoholic) beverages. Subjects were asked to indicate the weekly average frequency of 
consumption of each dietary item; intakes lower than once a week, but at least once a month, 
were coded as 0.5 per week. Nutrient and total energy intake was determined using an 
Italian food composition database. 21 The FFQ showed a satisfactory validity 22 and 
reproducibility.23
Details of the steps involved in DII calculation is described elsewhere.12,25 In order to 
compute the DII score, dietary information for each study participant were first linked to the 
regionally representative database that provided a robust estimate of a mean and a standard 
deviation for each of the 45 parameters (i.e., foods, nutrients, and other food components) 
considered in the DII definition.10 These parameters then were used to derive the subject’s 
exposure relative to the standard global mean as a z-score, derived by subtracting the mean 
of the regionally representative database from the amount reported, and dividing this value 
by the parameter’s standard deviation. To minimize the effect of “right skewing”, this value 
was converted to a centred percentile score, which was computed by doubling the raw 
percentile score and then subtracting 1. This score was then multiplied by the respective 
food parameter effect score (derived from a literature review on the basis of 1943 
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articles).10, 24 All of these food parameter-specific DII scores were then summed to create 
the overall DII score for every subject in the study. Higher scores indicate a pro-
inflammatory diet while lower scores indicate a more anti-inflammatory diet. The DII 
computed on this study’s FFQ includes data on 31 of the 45 possible food parameters 
comprising the DII: carbohydrates, proteins, fats, alcohol, fibers, cholesterol, saturated fatty 
acids, monounsaturated fatty acids, polyunsaturated fatty acids, omega 3, omega 6, niacin, 
thiamin, riboflavin, vitamin B6, iron, zinc, vitamin A, vitamin C, vitamin D, vitamin E, folic 
acid, beta carotene, anthocyanidins, flavan3ols, flavonols, flavanones, flavones, isoflavones, 
caffeine, and tea.
The DII was analysed as continuous and by quartiles computed among controls. Odds 
ratios(ORs) and the corresponding 95% confidence intervals (CIs) were estimated using 
unconditional logistic regression models including terms for age (quinquennial), sex, year of 
interview, study centre, education (<7; 7-11; ≥12 years), tobacco smoking (never; former; 
current: <15; 15-24, ≥25 cigarettes/day), and total energy intake (quintiles of the distribution 
of the controls).We further adjusted for the most frequent weekly occupational exposure to 
carcinogens in our study (i.e., aromatic amines, ammonia, sulfuric acid or hydrochloric, tar, 
pitch, asphalt, and soot, mineral oils and lubricants, gasoline, diesel engine fumes, foundry 
fumes, aluminum powder, concrete, lead, benzene, and other solvents) and selected diseases 
(i.e., diabetes, hypercholesterolemia, and obesity); however, the estimates did not change 
materially; thus, these factors were not included in the final, most parsimonious, model. 
Tests for linear trend were performed using the median value within each quartile as an 
ordinal variable. Stratified analyses were carried out according to sex, age (<65, ≥65 years), 
education (<7, ≥7 years) and tobacco smoking (never smokers, and ever smokers), and 
heterogeneity across strata was tested computing the difference in the -2 log likelihood of 
the models with and without the interaction terms. Statistical analyses were performed using 
SAS® 9.3 (SAS Institute Inc., Cary, NC).
Results
Cases were 690 patients aged 25–80 years (median 67 years) with incident BC (mostly 
transitional cell carcinoma), admitted to major general hospitals in the study areas. Nearly 
all BCs (n=642, 93.0%) were confirmed histologically on tumour tissue specimen from 
biopsy or surgery, while three additional cases were confirmed by cytology. Overall, 460 
patients (66.7%) were non-muscle-invasive (NMIBC, TNM pTis/Ta/T1) and 159 (23.0%) 
were muscle-invasive (MIBC, other T) BCs; 307 (44.5%) were well-differentiated or low 
grade (G1, G2) and 312 (45.2%) were poorly differentiated or high grade (G3, G4). Stage 
and grade was undefined for 71 (10.3%) patients. The controls were 665 patients frequency-
matched to cases by study centre, sex and 5-year age group (median age 66 years). The 
distribution of BC cases and controls according to selected factors is given in Table 1. Cases 
and controls had a similar distribution by study centre, sex, age, and education. Cases were 
more frequently smokers than controls.
The mean DII value was −0.63 (standard deviation, SD=1.94, range −5.42 to +4.48) among 
cases and −0.93 (SD=2.00, range −5.94 to +4.58) among controls, indicating a more pro-
inflammatory diet for cases. Characteristics of control subjects across quartiles of DII are 
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provided in Table 2. There were significant differences in tobacco smoking across quartiles 
of DII. Subjects in the highest quartile of DII were more likely to be current smokers.
Table 3 shows OR of BC and 95% CI according to continuous and quartiles of DII score. 
When used as a continuous exposure, one-unit increase in DII score was associated with 
increased odds for BC (ORContinuous= 1.11, 95% CI=1.03, 1.20), and when used as quartiles 
subjects in the highest DII score quartiles had 97% increased odds for BC compared to 
subjects in the lowest quartile (ORQuartile4vs1= 1.97, 95% CI=1.28, 3.03; p-trend=0.003).
Table 4 shows ORs of BC in strata of selected covariates. A stronger association was 
observed among females (ORQuartile4vs1= 5.73, 95% CI 1.46, 22.44), than males 
(ORQuartile4vs1= 1.83, 95% CI 1.14, 2.91) (p value for interaction 0.002), although the 
former estimate was based on many fewer cases and controls (24 cases and 28 controls in 
the highest quartile). Stronger associations – although in the absence of significant 
heterogeneity (p values >0.10) – were observed among subjects aged ≥65years 
(ORQuartile4vs1= 2.45, 95% CI 1.38, 4.34), education ≥7 years (ORQuartile4vs1= 2.22, 95% CI 
1.27, 3.88), and never smokers (ORQuartile4vs1= 4.04, 95% CI 1.51, 10.80). We also 
performed analysis separated by NMIBC and MIBC patients, and found DII to be associated 
with both NMIBC (ORQuartile4vs1= 1.92, 95% CI: 1.19, 3.08) and MIBC (ORQuartile4vs1= 
2.42, 95% CI: 1.18, 4.93). When we performed separated analysis by grade, we found DII to 
be associated with both grade 1 BC (ORQuartile4vs1= 1.79, 95% CI: 1.04, 3.09) and grade 2 
BC (ORQuartile4vs1= 2.13, 95% CI: 1.24, 3.67).
Discussion
This large multicentric Italian case-control study is the first attempt to investigate the 
association between inflammatory potential of diet and BC. We observed a two-fold excess 
risk of BC among individuals with a pro-inflammatory diet as expressed by high DII scores
High consumption of fruit and vegetables may reduce BC risk whereas high coffee 
consumption is inconsistently related to the increased risk of BC .6, 7 Fruits and vegetables 
are rich in various vitamins such as thiamin, niacin, vitamin E and carotenoids, which have 
anti-inflammatory effects and therefore contribute to lower DII scores.10 In a large European 
cohort study, consumption of carotenoids, such as beta-carotene, was found to reduce the 
risk of BC.25 In a prospective study conducted in Australia, increasing DII was observed to 
have a non-significant association with urothelial cancer.18
We observed a stronger association between DII scores and BC among non-smokers in this 
study. It is known that tobacco is a strongly pro-inflammatory agent.26 It could be that 
among smokers, or people exposed occupationally to pro-inflammatory carcinogens (or 
both) the pro-inflammatory state induced by smoking, or occupational carcinogens, 
overwhelms the countervailing anti-inflammatory effects of diet,27 further research should 
be conducted to explore this mechanism. It is important to note, however, that heterogeneity 
across strata of tobacco smoking was non-significant.
A significant positive association between DII and BC risk was observed in both men and 
women; however, the association was stronger in women. Although women had a lower rate 
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of smoking than men, tobacco use was accounted for in the analyses. Women also tend to 
have lower occupational exposures to workplace carcinogens,28 and this may help to explain 
the much lower BC incidence in women than men. At this juncture, there is no simple and 
satisfactory explanation for the stronger effect of the DII seen in women.
One of the possible mechanisms through which the observed positive association between 
DII and BC could occur is through oxidative and nitrative DNA damage in stem cells caused 
by chronic inflammation.29 Diet-related chronic inflammation plays a role in the 
upregulation of various cytokines such as tumour growth factor-b and IL-6 that, in turn, 
promote cell transformation, survival, proliferation of tumour cells, and metastasis.30
This hospital-based case-control study shares some of the limitations of such designs. 
Potential recall bias is possible; however, the comparability of recall between cases and 
controls was improved by interviewing all subjects in a hospital setting. As for selection 
bias, the study was hospital-based, but cases and controls were interviewed in the same 
hospital setting, came from comparable catchment areas, and their participation was 
comparable and almost complete. In addition, awareness about any particular dietary 
hypothesis in BC aetiology was limited in the Italian population. Among the strengths of this 
study are its large size and the use of a reproducible 23 and valid 22 FFQ. Also, the DII score, 
which takes into account both pro- and anti-inflammatory food parameters that characterize 
human diet, more accurately reflects the relationship of the inflammatory potential of diet to 
affect cancer risk than would single nutrients or diet components considered individually.
In conclusion, this study indicates a detrimental role of a pro-inflammatory diet, as measured 
by higher DII scores, on BC risk through a process of inflammation. These results have to be 
established in further studies to confirm this association.
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Table 1
Distribution of 690 cases of bladder cancer and 665 controls according to centre, sex, age and other selected 
variables. Italy, 2003-2014.
Cases Controls
No. % No. %
Centre
 Pordenone 242 35.1 250 37.6
 Milan 241 34.9 238 35.8
 Naples 129 18.7 100 15.0
 Catania 78 11.3 77 11.6
Sex
 Men 595 86.2 561 84.4
 Women 95 13.8 104 15.6
Age (years)
 < 60 148 21.5 178 26.8
 60-64 107 15.5 119 17.9
 65-69 164 23.8 147 22.1
 70-74 155 22.5 124 18.7
 ≥ 75
Education (years)a
116 16.8 97 14.6
 < 7 292 42.4 273 41.1
 7 - 11 224 32.5 215 32.3
 ≥ 12
Tobacco smokinga
173 25.1 177 26.6
 Never smokers 96 14.1 237 35.6
 Ex-smokers 310 45.5 284 42.7
 Current smokers
  < 15 cigarettes/day 79 11.6 53 8.0
  15-24 cigarettes/day 127 18.7 68 10.2
  ≥ 25 cigarettes/day 69 10.1 23 3.5
a
The sum does not add up to the total because of some missing values.
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Table 2
Participants’ characteristics across quartiles of dietary inflammatory index (DII) among 665 controls. Italy, 
2003-2014.
Characteristics
DII quartiles
−5.94, −
2.41
−2.40,−0.92 −0.91,0.41 0.42,4.58 p valuea
No. (%) No. (%) No. (%) No. (%)
Sex 0.15
 Male 139 (83.7) 135 (80.8) 148 (89.7) 139 (83.2)
 Female 27 (16.3) 32 (19.2) 17 (10.3) 28 (16.8)
Age (years) 0.66
 <60 37 (22.3) 41 (24.6) 52 (31.5) 48 (28.7)
 60-64 33 (19.9) 30 (18.0) 27 (16.4) 29 (17.4)
 65-69 44 (26.5) 36 (21.6) 38 (23.0) 29 (17.4)
 70-74 28 (16.9) 34 (20.4) 29 (17.6) 33 (19.8)
 ≥75 24 (14.5) 26 (15.6) 19 (11.5) 28 (16.8)
Education (years) 0.29
 <7 74 (44.6) 70 (41.9) 61 (37.0) 68 (40.7)
 7-11 53 (31.9) 49 (29.3) 65 (39.4) 48 (28.7)
 >11 39 (23.5) 48 (28.7) 39 (23.6) 51 (30.5)
Tobacco smoking b 0.007
 Never smokers 63 (37.9) 68 (40.7) 54 (32.7) 52 (31.1)
 Ex-smokers 76 (45.8) 71 (42.5) 72 (43.6) 65 (38.9)
 Current smokers
  <15 cigarettes/day 17 (10.2) 10 (5.9) 13 (7.9) 13 (7.8)
  15-24
  cigarettes/day
9 (5.4) 14 (8.4) 21 (12.7) 24 (14.4)
  ≥25
  cigarettes/day
1 (0.6) 4 (2.4) 5 (3.0) 13 (7.8)
ap value for Chi-square test
b
The sum does not add up to the total because of some missing values
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Table 3
Odds ratios (OR) of bladder cancer and corresponding 95% confidence intervals (CI) according to dietary 
inflammatory index (DII) among 690 cases and 665 controls. Italy, 2003-2014.
DII quartiles, OR (95% CI) p value
for trend
DII
continuous
−5.94, −2.41 −2.40, −0.92 −0.91,0.41 0.42,4.58
Cases/Contro
ls
124/166 180/167 179/165 207/167 690/665
Model 1a 1 b 1.56(1.11,2.17)
1.64 (1.11,
2.35)
2.11 (1.41,
3.14)
<0.0001 1.17 (1.08,
1.26)
Model 2c 1 b 1.46 (1.02,2.08)
1.46 (0.99,
2.14)
1.97 (1.28,
3.03)
0.003 1.11 (1.03,
1.20)
aAdjusted for age, sex, year of interview, study centre, and total energy intake.
b
Reference category.
c
Model 1 additionally adjusted for education (<7; 7-11; ≥12 years), and tobacco smoking (never; former; current: <15; 15-24; ≥25 cigarettes/day).
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Table 4
Odds ratios (OR) of bladder cancer and corresponding 95% confidence intervals (CI) according to quartiles of 
dietary inflammatory index (DII), among 690 cases and 665 controls, in strata of selected covariates, Italy, 
2003-2014.
Cases/
Controls DII quartiles, OR (95% CI)
a
ptrend pinteraction
−5.94, −
2.41
−2.40,−0.92 −0.91,0.41 0.42,4.58
Sex 0.002
 Male 595/561 1 b 1.39 (0.95, 2.03) 1.12 (0.74,1.70)
1.83 (1.14,
2.91)
0.03
 Female 95/104 1 b 2.56 (0.83, 7.89) 11.27 (3.23,39.31)
5.73 (1.46,
22.44)
0.004
Age (years) 0.59
 <65 255/297 1 b 1.25 (0.70, 2.22) 1.30 (0.71,2.38)
1.53 (0.79,
2.96)
0.21
 ≥65 435/368 1 b 1.63 (1.04, 2.56) 1.53 (0.92,2.52)
2.45 (1.38,
4.34)
0.004
Education
(years)
0.88
 <7 292/273 1 b 1.46 (0.84, 2.53) 1.42 (0.77,2.61)
1.56 (0.77,
3.14)
0.23
 ≥7 397/392 1 b 1.52 (0.95, 2.44) 1.41 (0.85,2.33)
2.22 (1.27,
3.88)
0.009
Tobacco smoking 0.36
 Never
 smokers
96/237 1 b 1.42 (0.64, 3.14) 3.06 (1.26,7.44)
4.04 (1.51,
10.80)
0.003
 Ever smokers 585/428 1 ba 1.58 (1.06, 2.34) 1.41 (0.92,2.15)
1.96 (1.22,
3.15)
0.01
aAdjusted for age, sex, year of interview, study centre, education (<7; 7-11; ≥12 years), tobacco smoking (never; former; current: <15; 15-24; ≥25 
cigarettes/day), and total energy intake, when appropriate.
b
Reference category.
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